Drug Profile
Research programme: protein-protein interaction modulators - GlaxoSmithKine/Priaxon
Alternative Names: PPIs - GlaxoSmithKline/PriaxonLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GlaxoSmithKline; Priaxon
- Developer GSK; Priaxon
- Class Small molecules
- Mechanism of Action Signal transduction pathway modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Undefined in Germany
- 07 Jan 2013 Early research in Undefined indication in Germany (unspecified route)